Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_assertion type Assertion NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_head.
- NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_assertion description "[Anti-CD20 B cell depletion therapy (BCDT) is very effective for some patients with rheumatoid arthritis (RA); however the pathogenic role of B lymphocytes in RA and the primary targets of BCDT are unknown.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_provenance.
- NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_assertion evidence source_evidence_literature NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_provenance.
- NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_assertion SIO_000772 20435928 NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_provenance.
- NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_assertion wasDerivedFrom befree-2016 NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_provenance.
- NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_assertion wasGeneratedBy ECO_0000203 NP809633.RApng8XsWw45unw1TvgAXw2KaRbnqFZlzXE32hdi_9l-U130_provenance.